On the other hand, expression levels of both c-Myc and acetylated c-Myc were unaltered in normal human mononuclear cells on treatment with HDACi, implying that c-Myc regulation in myeloma cells is a tumor-specific process (Fig. 5C). The gene discussed is MYC; the disease is plasma cell myeloma.